期刊文献+

系统性红斑狼疮治疗前后外周血共刺激分子表达的变化和意义 被引量:1

Costimulators in patients with systemic lupus erythematosus before and after treatment
下载PDF
导出
摘要 目的探讨共刺激分子表达水平在系统性红斑狼疮(SLE)患者治疗前后的变化及其意义。方法采用免疫荧光标记流式细胞仪检测技术,对SLE患者和正常人外周血单个核细胞膜表面的共刺激分子表达水平进行测定分析。结果①与正常人相比,SLE患者CD28分子表达显著降低(P<0.01),其中双标记CD4+CD28+、CD8+CD28+T细胞均显著减少(P<0.01),4-1BB分子表达显著增高(P<0.01);②患者CD28分子、CD4+CD28+及CD8+CD28+T细胞与SLE病情活动指数(SLEDAI)呈负相关(分别为P<0.01、P<0.01、P<0.05),4-1BB分子与SLEDAI呈正相关(P<0.01);③患者治疗后CD28分子、CD4+CD28+及CD8+CD28+T细胞随病情缓解而上升(P<0.01),4-1BB分子随病情缓解而下降(P<0.01)。结论共刺激分子表达异常在SLE发病机制中可能具有重要作用,其中CD28分子、4-1BB分子、CD4+CD28+及CD8+CD28+T细胞对监测病情活动和判断疗效可能具有重要意义。 Objective: To investigate the level of costimulators in patients with systemic lupus erythematosus (SLE) before and after treatment. Methods: The level of costimulators in peripheral blood of SLE patients before and after treatment and normal persons were detected by immunofluorescence lebelled technology and flow cytometry analysis. Results: ①Compared with normal subjects, the level of CD28 including CD4+CD28+,CD8+CD28+ T cells in peripheral blood of SLE patients was significantly decreased (P < 0.01), while the level of 4-1BB was increased (P < 0.01). ②The change in CD28 including CD4+CD28+,CD8+CD28+ T cells correlated with SLE disease activity index (SLEDAI) negatively (P < 0.01) and the change in 4-1BB correlated with SLEDAI positively. ③The level of CD28 was increased (P < 0.01), while the level of 4-1BB was decreased (P < 0.01)when the disease was controlled. Conclusions: Abnormal expression of costimulators may play some roles in pathogenesis of SLE. CD28, 4-1BB, CD4+CD28+ and CD8+CD28+ T cells may be useful indicators in the observation of disease activity and efficacy assessment of treatment.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2004年第2期84-86,共3页 Journal of Clinical Dermatology
基金 国家重点基础研究项目基金资助课题(2001CB510003)
关键词 红斑狼疮 系统性 共刺激分子 病情活动指数 lupus erythematosus, systemic costimulator disease activity index(DAI)
  • 相关文献

参考文献9

  • 1[1]Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE [J]. Arthritis Rheum,1992, 35(6): 630-640.
  • 2[2]Zhou ZH, Wang JF, Wang YD, et al. An agonist anti-human CD40 monoclonal antibody that induces dendritic cell formation and maturation and inhibits proliferation of a myeloma cell line[J]. Hybridoma, 1999,18(6):471-478.
  • 3王江方,张学光,周照华,邱玉华,潘建忠.Enhancement of T cell immune response to lymphoma cells by CD28/CD80 alternative pathway[J].Progress in Natural Science:Materials International,2000,10(1):42-48. 被引量:1
  • 4[4]Daikh D, Wofsy D, Imboden JB. The CD28-B7 costimulatory pathway and its role in autoimmune disease [J]. J Leukoc Biol,1997,62(2): 156-162.
  • 5[5]Greenfield EA,.Nguyen KA, Kuchroo. VK. CD28/B7 costimulation:a review[J]. Cri Rev Immunol,1998,18(5): 389-418.
  • 6[6]Mugnaini N, Egeland T, Spurkland A, et al. The T cell receptor repertoire of CD8 +CD28- T lymphocytes is dominated by expanded clones that persist over time [J]. Clin Exp Immunol,1999,117(2): 298-303.
  • 7[7]Kaneko H, Saito K, Hashmoto H, et al. Preferential elimination of CD28+T cells in systemic lupus erythematosus (SLE) and the relation with activation induced apoptosis[J]. Clin Exp Immunol,1996,106(2): 218-229.
  • 8[8]Tan JT, Whitmire JK, Ahmed R, et al. 4-1BB Ligand,a member of the TNF family, is important for the generation of antiviral CD8 T cell responses[J]. J Immunol, 1999,163(9):4859-4868.
  • 9[9]Sica G, Chen L. Biochemical and immunological characteristics of 4-1BB(CD137) receptor and ligand and potential applications in cancer therapy[J]. Arch Immunol Ther Exp Warsz, 1999,47(5):275-279.

二级参考文献1

同被引文献6

  • 1张榕,罗晓光,张晓莉,赵丽娟.系统性红斑狼疮患者CD4^+ T细胞上CD137的表达[J].中国免疫学杂志,2007,23(2):167-169. 被引量:4
  • 2HURTADO J C, KIM S H, POLLOK K E, et al. Potential role of 4 - 1 BB in T cell activation Comparison with the costimulatory molecule CD28 [J]. J Imuunol, 1995,155 (7) : 3360 - 3367.
  • 3BRETCHER P A. A two - step, two - signal model for the primary activation of precusor helper T cell [J]. Proc Natl Acad Sci USA, 1999, 96( 1 ) : 185 - 190.
  • 4FOELL J. STRAHOTIN S, O'NEIL S P, et al. CD137 eostimulatory T cell receptor engagement reverses acute disease in lupus - prone NZB ×NZWF1 mice[J]. JClinInvest, 2003, 111(10): 1505 - 1518.
  • 5SUN Y, CHEN H M, SUBUDHI S K, et al. Costimulatory molecule - targeted antibody therapy of a spontaneous autoimmune disease[J].Nature Med, 2002, 8(12): 1405-1413.
  • 6张榕,王闯,赵丽娟,郭韵,肖卫国,姜奕.SLE患者T淋巴细胞4—1BB的表达及其临床意义[J].医学临床研究,2009,26(2):180-183. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部